- Acknowledgements
- Acronyms & abbreviation
- Executive summary
- 1. Introduction
- 2. Guideline development process
- 3. Evidence and recommendations
- 4. Implementation considerations
- 5. Publication, dissemination, and evaluation
- References
- Annex 1. Guideline Development Group (GDG) members
- Annex 2. Assessment of conflict of interest
- Annex 3. Scoping questions
- Annex 4. Background question: Association of physical health conditions with severe mental disorders
- Annex 5. Evidence review methodology
- Annex 6. Drug – drug interactions
- Glossary